A58 Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Scale & Membership GrowthLarge, diversified membership across commercial, Medicare and Medicaid supports durable revenue scale and underwriting diversification. Steady membership and multi-year revenue growth create cost leverage, broader negotiating power with providers, and resilient premium inflows over a multi-quarter horizon.
Improved Cash GenerationA meaningful TTM free cash flow rebound and stronger operating cash flow underpin capital allocation flexibility. Consistent FCF coverage of earnings allows funding for buybacks, investments in Carelon/AI and potential regulatory payments while preserving liquidity across the next several quarters.
Carelon Clinical & Product TractionMeasured clinical outcomes and post-acute savings validate Carelon's integrated care model and support scalable third-party revenue. Demonstrable readmission and cost improvements strengthen competitive differentiation and position the services business to capture durable demand for value-based care.
Bears Say
CMS Risk-adjustment Accrual & Regulatory TimelineA sizable accrual and looming CMS compliance deadlines create regulatory and timing uncertainty that can materially affect cash flows and enrollment operations. Potential sanctions, remediation costs and ongoing oversight raise execution risk and could limit Medicare Advantage growth flexibility.
Medicaid Margin & Membership PressureSustained Medicaid membership declines and a negative operating margin expectation imply structural headwinds from eligibility reverifications and reimbursement dynamics. Persistent negative Medicaid profitability can weigh on consolidated margins and require cross-subsidization or pricing adjustments.
Balance-sheet Data InconsistencyAn unexplained sharp shift in reported total debt undermines transparency around leverage and liquidity. Even with equity growth and moderate leverage historically, such data discontinuities complicate capital planning and risk assessment for multi-quarter stress scenarios or large regulatory cash outflows.
Elevance Health News
A58 FAQ
What was Elevance Health, Inc.’s price range in the past 12 months?
Currently, no data Available
What is Elevance Health, Inc.’s market cap?
Currently, no data Available
When is Elevance Health, Inc.’s upcoming earnings report date?
Elevance Health, Inc.’s upcoming earnings report date is Jul 22, 2026 which is in 22 days.
How were Elevance Health, Inc.’s earnings last quarter?
Elevance Health, Inc. released its earnings results on Apr 22, 2026. The company reported $10.169 earnings per share for the quarter, beating the consensus estimate of $8.746 by $1.424.
Is Elevance Health, Inc. overvalued?
According to Wall Street analysts Elevance Health, Inc.’s price is currently Undervalued.
Does Elevance Health, Inc. pay dividends?
Elevance Health, Inc. does not currently pay dividends.
What is Elevance Health, Inc.’s EPS estimate?
Elevance Health, Inc.’s EPS estimate is 5.01.
How many shares outstanding does Elevance Health, Inc. have?
Currently, no data Available
What happened to Elevance Health, Inc.’s price movement after its last earnings report?
Elevance Health, Inc. reported an EPS of $10.169 in its last earnings report, beating expectations of $8.746. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Elevance Health, Inc.?
Currently, no hedge funds are holding shares in CH:A58
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Elevance Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$336.91 (― Downside)
$336.91 (― Downside)
Insider Transactions
Sold Shares
Worth CHF674.3K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.11%
12-Months-Change
Fundamentals
Return on Equity
11.95%
Trailing 12-Months
Asset Growth
5.10%
Trailing 12-Months
Company Description
Elevance Health, Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
A58 Company Deck
A58 Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong execution and tangible operational improvements that drove a Q1 EPS beat, an upgraded full-year EPS guide, share repurchases and growing demand for integrated clinical and pharmacy offerings. Management also highlighted meaningful AI investments and measurable clinical results from Carelon/CareBridge (20% readmission reduction, >10% post-acute savings). Offsetting these positives are a material $935 million accrual related to a CMS historical risk-adjustment matter, a $129 million optimization charge, ongoing elevated Medicaid cost trends and some margin pressure and investment-driven cadence at Carelon. On balance the positives (guidance raise, underlying business beats, membership growth, cash generation and scalable AI/Carelon proof points) outweigh the negatives (one-time accrual, Medicaid pressure, Carelon margin timing), supporting a constructive outlook with manageable risks.View all CH:A58 earnings summariesA58 Stock 12 Month Forecast
Average Price Target
$336.91
Options Prices
Currently, No data available
---